NCT03011788

Brief Summary

The aim of this randomized trial is to compare the proportion of patients achieving an adequate bowel preparation after a 1-day split-dose 4-liter PEG-based bowel preparation regimen (Golytely, Braintree Laboratory Inc, MA, USA) vs. the same regimen given on 2 consecutive days in a population identified as high risk for an inadequate bowel preparation. 2\. Research Design: This study is a single-center prospective randomized study at the West Haven VAMC. 3\. Methodology:

  1. 1.Primary endpoint: Adequate bowel preparation as defined by a Boston Bowel Preparation Scale (BBPS) score of 2 or 3 (on scale of 0-3) in all 3 colon segments (left, transverse, and right).
  2. 2.Secondary endpoints: Adenoma detection rate, polyp detection rate, sessile serrated polyp/adenoma detection rate, patient tolerability of preparation using the validated Mayo clinic bowel prep tolerability questionnaire, adverse events potentially related to bowel preparation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 5, 2017

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

December 3, 2019

Status Verified

December 1, 2019

Enrollment Period

3.9 years

First QC Date

January 3, 2017

Last Update Submit

December 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Boston Bowel Preparation Scale (BBPS)

    Boston Bowel Preparation Scale (BBPS) score of 2 or 3 (on scale of 0-3) in all 3 colon segments

    Day 1

Secondary Outcomes (2)

  • Adenoma detection rate

    Day 1

  • patient tolerability of preparation using the validated Mayo clinic bowel prep tolerability questionnaire

    Day 1

Study Arms (2)

Single day

ACTIVE COMPARATOR

Single day Golytely purge 4L purge

Drug: Golytely Oral Solution

2 day colon purge

ACTIVE COMPARATOR

Two days of Golytely purge 8L purge

Drug: Golytely Oral Solution

Interventions

Bowel purge prior to,colonoscopy

Also known as: Bowel purge
2 day colon purgeSingle day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Risk factors that increase likelihood of poor bowel prep

You may not qualify if:

  • prior colon resection
  • Women of child bearing age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West Have VAMC

West Haven, Connecticut, 06516, United States

RECRUITING

MeSH Terms

Interventions

Golytely

Central Study Contacts

Anil Nagar, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Of Endoscopy, Associate professor Internal Medicine

Study Record Dates

First Submitted

January 3, 2017

First Posted

January 5, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2020

Study Completion

December 1, 2021

Last Updated

December 3, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations